Obstetrics/Gynecology
RSSArticles
-
At-home HIV test kit to undergo FDA review
Increasing access to HIV testing is a prevention priority in the United States. Health officials estimate more than 25% of those infected are transmitting HIV to others because they are unaware that they are infected. -
Why is the IUD Number One?
There are several reasons the IUD tops the list. IUDs are effective, safe, convenient, cost effective, and fully reversible. -
CTUpates: Drug label information moves to the Internet
In preparing for a counseling session on contraceptives, you decide to review labeling for a number of birth control pills. How can you be sure you have the most up-to-date information in your files? -
Full February 2006 Issue in PDF
-
BRCA1 and BRCA2 Carriers and Hormone Therapy
Rebbeck and colleagues identified a cohort of 462 women with BRCA1/2 mutations from 13 medical centers in North America and Europe. -
Laparoscopic Bilateral Salpingo-oophorectomy in Breast Cancer Patients after Transverse Rectus Abdominis Myocutaneous Flap Reconstructive Surgery
It has become increasingly documented that removal of the ovaries in high-risk women can not only reduce the risk of gynecologic malignancy but also improve the outcome of women with breast cancer. -
Pharmacology Watch: FDA Recommends Approval of Muraglitazar, But May Need To Reconsider
Which Antipsychotics Are More Dangerous?; Should CPOE Undergo Evaluation?; New Treatment for Tennis Elbow; FDA Actions -
Clinical Briefs in Primary Care supplement
-
Full January 2006 Issue in PDF
-
Does Aggressive Surgery Only Benefit Patients with Less Advanced Ovarian Cancer? Results from an International Comparison Within the SCOTROC-1 Trial
The positive relationship between the amount of surgical residual following primary extirpation of advanced ovarian cancer and survival thereafter has been one frequently cited to justify aggressive surgical evaluation.